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Introduction: Synchronous adrenalectomy has become dispensable since retrospective studies have demonstrated
no survival benefit when preoperative imaging was normal. The aim of this large bi-institutional study was to
determine the appearance of synchronous and metachronous metastases to the adrenal gland as detected by
computed tomography and positron emission tomography or magnetic resonance imaging with consecutive
surgical removal of suspicious lesions.
Materials and methods: We retrospectively reviewed the clinico-pathological records of 2720 patients from two
urological centers who underwent radical or partial nephrectomy due to kidney cancer disease. Synchronous
adrenalectomy was carried out in 548 of all cases (20.2%). Metachronous adrenalectomy was performed in 24 cases
due to suspicious imaging in follow-up.
Results: Metastatic spread in patients with synchronous adrenalectomy was found in 29/548 cases (5.3%), as
suspected. In metachronous procedures positive pathological results were found in 24 of 24 cases. Among them
54% of all tumor recurrences were detected in the contralateral adrenal gland.
Conclusions: In case of preoperative suspicious imaging an intraoperative frozen section should be performed.
Radiological investigations are of high diagnostic value for detecting metachronous tumor growth into the adrenal
gland. Surgery in this scenario should be recommended due to the high malignancy rate reported here.
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Since the introduction of the radical nephrectomy approach
for malignant kidney disease by Robson including
removal of the adrenal gland more than half a century
ago, this approach has been adopted towards organ- and
nephron-sparing procedures (O'Malley et al. 2009).
The incidence of synchronous metastasis into the
ipsilateral adrenal gland has been reported to be 2-10%
(Robey and Schellhammer 1986; Winter et al. 1990).
Although in advanced local disease a relevant number of* Correspondence: peters.inga@mh-hannover.de
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in any medium, provided the original work is ppatients diagnosed with renal cell cancer (RCC) are
metastasized at the time of diagnosis (Hock et al. 2002),
metachronous adrenal metastasis is a rare event. However,
in general, metastasis to the adrenal gland is the second
most common tumorous lesion in the adrenal glands after
benign adrenocortical adenomas. In the case of metastatic
RCC (mRCC) the incidence is from 7% to 23% in autopsy
series (Wunderlich et al. 1999).
In a recent study Weight et al. demonstrated that patients
do not have a benefit either in improved cancer-specific
survival or in risk reduction of metachronous adrenal
metastasis by performing simultaneous adrenalectomy.
The authors reported synchronous ipsilateral tumor
involvement of 2.2% (n=88) and a metachronous metastasisn Open Access article distributed under the terms of the Creative Commons




Figure 1 CT (A) and PET-CT (B) scan of patients with ipsilateral metachronous metastasis after radical nephrectomy on the right (A) and
left (B) side. Arrows (white and black) mark the corresponding suspicious lesion.
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(Weight et al. 2011). The latter finding was confirmed
by other investigators, who concluded that in case of
unsuspicious imaging, low tumor stage, and normal
palpation during surgery the adrenal gland can be left
in situ (Kobayashi et al. 2003; Kuczyk et al. 2002;
Kuczyk et al. 2005). Since radiographic investigations
have improved during the last decades, accounting for
an increase of small adrenal lesions, it might be debatablethat in case of positive radiological findings additional
surgery seems to be necessary. We therefore analyzed
retrospectively in a bi-center study model the number of
positive pathological results (i.e. metastasis) in the
adrenal gland after a tumor nephrectomy in a large
cohort of patients with simultaneous adrenalectomy
and with metachronous adrenalectomy due to a suspicious
radiological finding in computer tomography (CT) and
positron emission tomography (PET-CT) or magnetic
Figure 2 Distribution and numbers of synchronous and metachronous metastases to adrenal gland in RCC patients during 1996-2010/2011.
Patients’ data were retrospectively analyzed regarding clinical and histopathological parameters. Blue bars indicate the synchronous and red bars
the metachronous metastases.
Peters et al. SpringerPlus 2013, 2:293 Page 3 of 6
http://www.springerplus.com/content/2/1/293resonance imaging (MRI). The main aim of this study is to
discuss the aspects of simultaneous biopsy during radical
nephrectomy surgery in case of RCC and the need of
resection of a suspicious lesion in the adrenal gland in
follow-up CT scans of patients with RCC history.
Material and methods
Study design
A retrospective bi-center study was performed. Institutional
Ethical Review Boards approved the study protocol. Clinical
and pathological results in the Urological Departments of
the Hospital of Plzeň with 1680 patients (pts.) who
underwent nephrectomy in the period 1996–2011 andFigure 3 Distribution of positive and negative pathologic results in th
bars demonstrate the numbers of patients where the histopathological res
metastasis results in synchronous compared to metachronous events (p <
and no metastasis was found.1040 pts. from Hannover Medical School (MHH) in
the period 1996–2010 were included in the analysis.
All patients were initially diagnosed histologically with
an RCC. Laparoscopic and open radical or partial
nephrectomies were performed as surgical approaches.
Simultaneous adrenalectomy was performed in 232
(13.8%) patients of the Plzeň and in 316 (30.4%) patients
of the MHH cohort. Along with the retrospective design
of the study the lack of controlled follow-up after initial
nephrectomy or partial nephrectomy of the patients was a
major limitation of the study. Patients were resubmitted
to surgical departments because of suspicious lesions in
the adrenal glands in non-standardized routine follow-upe synchronous and metachronous adrenalectomy cohort. Blue
ult was negative whereas red bars show the frequency of positive
0.001, chi-square test). Green bars indicate tissues in which infiltration
Table 1 Clinicopathological parameters and patients’
characteristics of synchronous and metachronous
adrenalectomy group (TNM 7th revision)
Parameter Adrenalectomy
Synchronous (%) Metachronous (%)






A 131 (23.9) 2 (8.3)
B 88 (16.1) 7 (29.2)
T1-T2 3 (0.5) 3 (12.5)
T2
A 47 (8.6) 1 (4.2)
B 5 (0.9) 0
T3
A 135 (24.6) 5 (20.8)
B 111 (20.3) 3 (12.5)
C 6 (1.1) 0
T4 12 (2.2) 1 (4.2)
not known 10 (1.8) 2 (8.3)
N0 502 (91.6) 22 (91.7)
N1 18 (3.3) 0
N2 22 (4) 0
not known 6 (1.1) 2 (8.3)
M0 459 (83.8) 17 (70.8)
M1 82 (15) 5 (20.8)
not known 7 (1.3) 2 (8.3)
Fuhrman grade
(n, %)
1 122 (22.3) 4 (17.7)
2 301 (54.9) 15 (62.5)
3 97 (17.7) 4 (16.7)
4 10 (1.8) 0
not known 18 (3.3) 1 (4.2)
Side (n, %)
Left 274 (50) 9 (37.5)
Right 273 (49.8) 13 (54.2)
Both 1 (0.2) 2 (8.3)
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randomized controlled trial.
Patient characteristics and surgery
In total 2720 patients underwent tumor surgery because of
RCC. In 548 cases an adrenalectomy was simultaneously
performed. The main reason for radical surgery with
simultaneous adrenalectomy was a locally advanced tumor
disease (T3/T4 stage) with uncertain preoperative imaging
findings where differentiation of tumor involvement in
contrast to periadrenal inflammation, tumor extension, or
adhesion was difficult. Remaining nephrectomies were
performed as adrenal-sparing surgery. Totally, in 348 men
and 200 female patients the adrenal gland was resected
during the procedure of nephrectomy. A metachronous
adrenalectomy was performed in 24 cases, including 16
male and 8 female patients due to a suspicious finding in
follow-up CT or PET-CT scan (see Figures 1 and 2). The
main surgical approach for contralateral metachronous
adrenalectomy was laparoscopic surgery (13/24 cases; 54%).
In 2 (8.4%) cases the ipsilateral side after previous radical
nephrectomy was affected and laparoscopic adrenalectomy
was performed. In 13 cases the contralateral side of the
primary tumor location was affected and in two cases
bilateral metachronous metastatic spread was detected
without any other distant metastasis. Tumors were staged
according to the TNM system (Elmore et al. 2003).
All resected adrenal glands were examined with
regard to cancer involvement or solitary metastasis. Table 1
presents the detailed clinicopathological parameters and
characteristics patients with synchronous or metachronous
metastatic disease.
Statistical analysis
For group comparison the chi-square test and Fisher’s
exact test were used. All statistical analyses were
performed using the statistical software R version 2.10.0
(Hothorn 2003). A value of p ≤ 0.05 was considered to
be statistically significant.
Results
A significant statistical difference according to clinico-
pathological parameters of both groups (synchronous and
metachronous) was not found (p values not shown.) Both
groups were homogeneous in regard of sex, tumor status,
nodal involvement or distant metastasis as well as
tumor grade. However, a significant difference was
found between the pathological results of resected adrenal
glands. In contrast to the synchronous group, 29 out of 548
cases (5.3%) were metastasis positive, and a 100%
histological positivity for clear cell renal carcinoma (ccRCC)
in the metachronous group (24/24; 100%; p < 0.001,
Figure 3) was detected. The mean time to the development
of a synchronous metastasis was 52.3 months. Time tometastasis varies from a minimum of 3 months to a
maximum of 157 months after initial radical surgery.
A simultaneous tumor infiltration/involvement of the
adrenal gland was found in 16 cases (3%) of all
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examination revealed a benign hyperplasia or cortical
adenoma (Figure 3).
Discussion
A routine ipsilateral adrenalectomy is not recommended
in radical nephrectomy (Levy et al. 1998; Kuczyk,
Munch et al. 2002) when no suspicious result is detected
in imaging modalities or intraoperative findings are
suspicious for tumor spread. In an earlier study we
found that only a minority of RCC patients (1%) present
with a solitary adrenal metastasis without other metastatic
sites at the time of diagnosis (Kuczyk, Wegener et al. 2005).
In cases where adrenal metastases originating from RCC
were found, an advanced and disseminating disease could
be found in approx. 96% (Wunderlich, Schlichter et al.
1999; Winter, Miersch et al. 1990). Kobayashi et al. demon-
strated in a retrospective study that there is no statistically
significant difference in disease-specific survival in patients
undergoing ipsilateral simultaneous adrenalectomy and
patients with adrenal-sparing radical nephrectomy because
of RCC (Kobayashi, Nakamura et al. 2003). We also noted
a low incidence (5.3%) of synchronous adrenal metastasis.
Interestingly we observed that, to our knowledge for
the first time, regarding a suspicious lesion in the adrenal
gland in follow-up CT scans a histological positivity
(i.e. metastasis) of 100% could be found. The mean
time to the development of a metachronous metastasis
was 52.3 months. Both PET-CT coupled with CT or MRI
are the diagnostics of choice in case of suspected adrenal
lesions and in case of suspicious findings a preoperative
hormonal evaluation is recommended (Sancho et al. 2012).
In experienced hands a minimal invasive approach
especially to patients with contralateral metachronous
metastasis after previous radical nephrectomy is a
feasible option (Rane et al. 2011; Abel et al. 2011).
This study supports the known results that synchronous
metastasis is a rare event in RCC patients. Hence in case of
suspicious lesions in follow-up imaging after adrenal-
sparing radical nephrectomy a metastasis is very likely and
a surgical resection should be performed. In case of
advanced tumor disease at the time of diagnosis it should
be discussed if in case of uncertain imaging prior to surgery
(Tsui et al. 2000), an intra-operative biopsy could be helpful
in deciding whether a simultaneous adrenalectomy
should be performed. Otherwise postoperative hormonal
dysfunction and necessity of hormonal replacement can
be the result, particularly with regard to the risk of
metachronous metastasis. Regarding long-term intervals
to metastasis, frequent patient follow-up should be
recommended. Our study suffers from bias in patient
selection and retrospective data collection, which
constitute study limitations. However, the presented data
suggest the need of a routine and time-controlled follow-upof the patient and in case of a suspicious lesions in either
CT- or MRI scan, the necessity of a surgical resection
should be discussed. A prospective study with a long-term
follow-up is needed to further elucidate this aspect.
Conclusion
Synchronous adrenalectomy is not routinely recommended
with nephrectomy. In case of pre-operative suspicious
imaging an intraoperative frozen section and investiga-
tions by the surgeon should be performed. In case of
metachronous tumor growth within the adrenal gland,
PET-CT/CT or MRI should be performed. In radiological
positive cases, a surgical resection of this lesion due to its
high probability of malignancy should be discussed.
Furthermore, frequent follow-ups of RCC patients
should be recommended due to the long mean time of
the development of a metachronous metastasis of
approximately 52 months.
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